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ABSTRACT 
 
Study aims were (1) to document adherence measurement using 3 different methods. (2) to determine the 
relationship between each methods. The study wasconducted using cross sectional design. Patients were followed-up 
for 6 months and adherences weremeasured after 1 and 6 months therapy. The methods used to measure the 
adherenceswere 1) Patient/parent-self reported ( MMAS-8 questionnaires); 2) Drug level assay and 3) seizure 
frequency observation. Participants enrolled were 50 patients with new-onset general epilepsy (Mage = 7.2 ± 2.0; 54 
% male; 46% female Indonesian). Patient/parent-self reported methods resulted mean overall adherence scores 
across patients during this 6-months period was 4.07 ± 1.15 (81.4%). Meanwhile phenytoin assay indicated only 
18% patients reached therapeutics concentration. Seizure frequency observation revealed 81% improvement in 
seizure frequency (t= 7.63, P=0.000) after 6 months therapy. Negative correlations were found between 
Parents/patients-self reporting with drug levels(rho=-0.082, P=0.59); Parents/patients-self reporting with seizure 
frequency(rho=-0.17, P=0.24).  Correlation between seizure frequency with phenytoin level was also proved by 
Spearman test as no significant (rho=0.12, P=0.42). 7 patients (14%) remain had seizure after 6 months but only 2 
patients were having miss dose. There were lack of correlation between the various methods of adherence 
measurement but it does not necessarily reflect a minimum in adherence. 
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INTRODUCTION 
 
Patient adherence to Antiepileptic Drug (AED) 
continues to be a cause of concern within epileptic 
patients. For individuals with epilepsy, adherence to 
medication is crucial in preventing or minimizing 
seizures and their cumulative impact on everyday 
life. Non-adherence to antiepileptic drugs can result 
in breakthrough seizures many months or years after 
a previous episode and can have serious 
repercussions on an individual’s perceived quality of 
life
1
.Stanaway et al
2
 found that 31% of seizures were 
precipitated by nonadherence to medication. And, as 
with other chronic medical conditions, estimates 
suggest that between 30% and 60% of patients with 
epilepsy are not adhere with their drug regimens. 
3,4,5
 
In assessing the effectiveness of prescribed 
medication there is a strong emphasis on the ability 
of the patient to adhere to the regime recommended 
by the clinician 
6,7. 
Various tools have been developed 
to measure adherence but have limitations. Most 
research has concentrated on quantifying levels of 
compliance/adherence without first defining what is 
meant by both terms 
8
. In a review of adherence 
studies, Vermeire et al
9
 report that adherence has 
largely been measured using process-orientated 
definitions involving number of doses missed or 
taken incorrectly rather than looking at the end result 
to health. As Farmer
10
 in his review of adherence 
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